Order directing doctors to prescribe only generic medicines put on hold

The orders issued by the National Medical Commission (NMC) which had barred doctors from prescribing medicines other than generic drugs has been put on hold with immediate effect. The decision was made after the Indian Medical Association (IMA) and the Federation of Resident Doctors Association approached the Centre and Union Health Minister Mansukh Mandaviya.

The National Medical Commission’s Registered Medical Practitioner (Professional Conduct) Regulations, 2023, had made the prescription of generic drugs mandatory for doctors, along with other directives. The regulatory body had stated that since generic medicines are 30 to 80 per cent cheaper than branded drugs, this new rule would lower healthcare costs.

The NMC’s orders have been opposed by doctors ever since it was notified. The doctors argued that the quality control of generic medicines is weak in India and such rules will put patients at risk.

A Public Interest Litigation (PIL) was also filed in the Supreme Court seeking stringent disciplinary actions against registered medical practitioners who do not prescribe generic alternatives to branded names.

Related Posts

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

New Delhi: AstraZeneca’s India-arm has partnered with National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, to build clinical research capabilities at 25 emerging geographies in a bid to extend…

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Following a bumpy regulatory road that involved a refusal-to-file, ImmunityBio has won FDA approval to expand Anktiva into papillary-only non-muscle-invasive bladder cancer (NMIBC). Wednesday’s approval comes nearly three months ahead…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction